Tag: BioCardia

BioCardia announces FDA review completion of ongoing cell therapy for heart...

BioCardia, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, has announced that the US Food and Drug...

BioCardia submits 510(k) application to US FDA for its Avance steerable...

BioCardia has announced its 510(k) submission for US FDA clearance of the Avance steerable introducer, which is designed for introducing various cardiovascular catheters into...

Positive 12-month data presented for CardiAMP Cell Therapy System for heart...

Positive 12-month data have been presented for the roll-in cohort of the pivotal CardiAMP Heart Failure Trial studying the investigational CardiAMP Cell Therapy System...